Literature DB >> 1506505

Psychological interventions with AIDS and HIV: prevention and treatment.

J A Kelly1, D A Murphy.   

Abstract

In the decade since acquired immune deficiency syndrome (AIDS) was first diagnosed, behavioral research has focused intensively on risk reduction change processes and, to a lesser extent, on mental health needs of persons with human immunodeficiency virus (HIV) conditions. Although research to date has yielded important findings for primary prevention efforts and has identified some psychological dimensions relevant to mental health interventions, there is a pressing need for much more systematic intervention outcome research in both the prevention/behavior change and emotional coping areas. Progress in these areas will be facilitated by better linkage of intervention approaches to behavioral theory; identification of intervention elements that produce HIV risk behavior change; evaluated field-testing of promising intervention models; continued focus on populations that remain at risk (such as gay men and injection drug users); and expansion of prevention efforts to urban, poor, and minority populations increasingly threatened as AIDS/HIV enters a "second wave." Although AIDS is still a relatively new problem, existing behavioral medicine conceptual models and intervention strategies can be adapted to meet the enormous challenges created by AIDS and HIV infection.

Entities:  

Mesh:

Year:  1992        PMID: 1506505     DOI: 10.1037//0022-006x.60.4.576

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  13 in total

1.  Condom use among female sex workers in China: role of gatekeepers.

Authors:  Hongmei Yang; Xiaoming Li; Bonita Stanton; Xiaoyi Fang; Ran Zhao; Baiqing Dong; Wei Liu; Shaoling Liang; Yuejiao Zhou; Yan Hong
Journal:  Sex Transm Dis       Date:  2005-09       Impact factor: 2.830

Review 2.  HIV/AIDS behind bars: an avenue for culturally sensitive interventions.

Authors:  N I Osemene; E J Essien; I G Egbunike
Journal:  J Natl Med Assoc       Date:  2001-12       Impact factor: 1.798

3.  Effects of two cognitive-behavioral interventions on immunity and symptoms in persons with HIV.

Authors:  R N Lucille Sanzero Eller
Journal:  Ann Behav Med       Date:  1995-12

4.  Keeping them in "STYLE": finding, linking, and retaining young HIV-positive black and Latino men who have sex with men in care.

Authors:  Lisa B Hightow-Weidman; Justin C Smith; Erik Valera; Derrick D Matthews; Patrick Lyons
Journal:  AIDS Patient Care STDS       Date:  2010-12-16       Impact factor: 5.078

Review 5.  Anxiety symptoms and disorders among adults living with HIV and AIDS: A critical review and integrative synthesis of the empirical literature.

Authors:  Charles Brandt; Michael J Zvolensky; Steven P Woods; Adam Gonzalez; Steven A Safren; Conall M O'Cleirigh
Journal:  Clin Psychol Rev       Date:  2016-11-17

6.  Triple jeopardy for HIV: substance using Severely Mentally Ill Adults.

Authors:  Jessy G Devieux; Robert Malow; Brenda G Lerner; Janyce G Dyer; Ligia Baptista; Barbara Lucenko; Seth Kalichman
Journal:  J Prev Interv Community       Date:  2007

7.  A Preliminary Examination of Sexual Orientation as a Social Vulnerability for Experiencing HIV/AIDS-related Stigma.

Authors:  Adam Gonzalez; Kristin S Weibust; Carol T Miller; Sondra E Solomon
Journal:  J Appl Soc Psychol       Date:  2011-05-17

8. 

Authors:  Yarimar Rosa Rodríguez; Nelson Varas Díaz
Journal:  Apunt Psicol       Date:  2008

9.  Size matters: community size, HIV stigma, & gender differences.

Authors:  Adam Gonzalez; Carol T Miller; Sondra E Solomon; Janice Yanushka Bunn; Daniel G Cassidy
Journal:  AIDS Behav       Date:  2008-09-25

10.  Methods to measure the impact of home, social, and sexual neighborhoods of urban gay, bisexual, and other men who have sex with men.

Authors:  Beryl A Koblin; James E Egan; Andrew Rundle; James Quinn; Hong-Van Tieu; Magdalena Cerdá; Danielle C Ompad; Emily Greene; Donald R Hoover; Victoria Frye
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.